Literature DB >> 7826272

Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy.

K Ricker1, M C Koch, F Lehmann-Horn, D Pongratz, N Speich, K Reiners, C Schneider, R T Moxley.   

Abstract

BACKGROUND: Previous investigations in three families have shown that proximal myotonic myopathy (PROMM) is not linked to the gene loci for myotonic dystrophy (DM) or to the loci of the genes of the muscle sodium and chloride channels associated with other myotonic disorders. It is important to extend our clinical knowledge of this interesting new disorder by studying other families. PATIENTS: Thirty-five patients in 14 new families; 27 patients were examined.
METHODS: Clinical examination, electromyography, muscle biopsy, DNA analysis.
RESULTS: The following findings were noted: proximal without distal weakness of the legs (n = 21); myotonia on electromyograms (n = 23); intermittent clinical myotonia (n = 17); cataracts (n = 24) and a number of the cataracts were identical to the type in DM (n = 11); and peculiar muscle pain (n = 14). A few patients had cardiac arrhythmias, and others had elevations in the concentrations of serum gamma-glutamyltransferase. None of the patients had significant muscle atrophy. Muscle biopsy specimens showed mild myopathic changes. All patients had normal trinucleotide (cytosine, thymine, and guanine) repeat size of the DM gene in leukocyte DNA. Muscle DNA probes from three patients showed findings identical to those of their leukocyte DNA probes.
CONCLUSIONS: Proximal myotonic myopathy is a new genetic disorder similar to, but distinct from, DM. Patients suspected of having DM but with negative DNA studies may have PROMM. The gene defect for PROMM awaits discovery. Because of the similarities between PROMM and DM, this discovery will not only shed light on the pathomechanism of PROMM, but it may also increase our understanding of DM.

Entities:  

Mesh:

Year:  1995        PMID: 7826272     DOI: 10.1001/archneur.1995.00540250029009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  21 in total

Review 1.  A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature.

Authors:  G Meola; V Sansone
Journal:  Ital J Neurol Sci       Date:  1996-10

2.  [Musculoskeletal pain as the most prominent feature in myotonic dystrophy type 2].

Authors:  A George; C Schneider-Gold; K Reiners; C Sommer
Journal:  Schmerz       Date:  2006-09       Impact factor: 1.107

Review 3.  Repeat expansion disease: progress and puzzles in disease pathogenesis.

Authors:  Albert R La Spada; J Paul Taylor
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

4.  Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)?

Authors:  C Abbruzzese; R Krahe; M Liguori; D Tessarolo; M J Siciliano; T Ashizawa; M Giacanelli
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

5.  Female patient with proximal myotonic myopathy and ventricular tachycardia.

Authors:  S Schenk; S Löscher; F Mickley; A Hartmann
Journal:  Z Kardiol       Date:  2005-11

6.  Laboratory abnormalities in patients with myotonic dystrophy type 2.

Authors:  Chad Heatwole; Nicholas Johnson; Bradley Goldberg; William Martens; Richard Moxley
Journal:  Arch Neurol       Date:  2011-09

7.  Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2).

Authors:  Claudio Catalli; Alessandra Morgante; Raniero Iraci; Fabrizio Rinaldi; Annalisa Botta; Giuseppe Novelli
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

8.  Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.

Authors:  Linda L Bachinski; Bjarne Udd; Giovanni Meola; Valeria Sansone; Guillaume Bassez; Bruno Eymard; Charles A Thornton; Richard T Moxley; Peter S Harper; Mark T Rogers; Karin Jurkat-Rott; Frank Lehmann-Horn; Thomas Wieser; Josep Gamez; Carmen Navarro; Armand Bottani; Andre Kohler; Mark D Shriver; Riitta Sallinen; Maija Wessman; Shanxiang Zhang; Fred A Wright; Ralf Krahe
Journal:  Am J Hum Genet       Date:  2003-09-10       Impact factor: 11.025

Review 9.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 10.  Recent advances in myotonic dystrophy type 2.

Authors:  Christina M Ulane; Sarah Teed; Jacinda Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.